| No. |
Proposition |
|
For |
Against |
Abstain |
| 1 |
Approval of the statutory financial statements for the fiscal year ended December 31, 2025 |
|
|
|
|
| 2 |
Approval of the consolidated financial statements for the fiscal year ended December 31, 2025 |
|
|
|
|
| 3 |
Allocation of the income and decision on the dividend amount |
|
|
|
|
| 4 |
Agreements provided for in Articles L.225-38 and seq. of the French Commercial Code |
|
|
|
|
| 5 |
Appointment of independent director |
|
|
|
|
| 6 |
Reappointment of Mrs. Valrie Beaulieu as independent director |
|
|
|
|
| 7 |
Approval of the information referred to in Article L. 22-10-9 I. of the French Commercial Code, pursuant to Article L. 22-10-34 I. of the French Commercial Code |
|
|
|
|
| 8 |
Approval of the components of compensation paid during the fiscal year ended December 31, 2025, or allocated in respect of the same fiscal year to Ms. Christel Heydemann, Chief Executive Officer, pursuant to II of Article L. 22-10-34 of the French Commercial Code |
|
|
|
|
| 9 |
Approval of the components of compensation paid during the fiscal year ended December 31, 2025, or allocated in respect of the same fiscal year to Mr. Jacques Aschenbroich, Chairman of the Board of Directors, pursuant to II of Article L. 22-10-34 of the French Commercial Code |
|
|
|
|
| 10 |
Approval of the 2026 compensation policy for the Chief Executive Officer, pursuant to Article L. 22-10-8 of the French Commercial Code |
|
|
|
|
| 11 |
Approval of the 2026 compensation policy for the Chairman of the Board of Directors, pursuant to Article L. 22-10-8 of the French Commercial Code |
|
|
|
|
| 12 |
Approval of the 2026 compensation policy for the Chairman of the Board of Directors, pursuant to Article L. 22-10-8 of the French Commercial Code |
|
|
|
|
| 13 |
Authorization to be granted to the Board of Directors to purchase or transfer Company shares |
|
|
|
|
| 14 |
Amendment of the article 13 of the Bylaws with the new rules on gender balance on the Board of Director |
|
|
|
|
| 15 |
Authorization granted to the Board of Directors to allocate free shares of the Company to executive Corporate Officers and certain Orange group employees and involving the waiver of shareholders' preferential subscription rights |
|
|
|
|
| 16 |
Delegation of authority to the Board of Directors to issue shares or complex securities reserved for members of savings plans and involving the waiver of shareholders' preferential subscription rights |
|
|
|
|
| 17 |
Authorization to the Board of Directors to reduce the capital through the cncellation of shares |
|
|
|
|
| 18 |
Powers for formalities |
|
|
|
|